| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Learn A Lesson from Oprah |
|
Main Subject - Learn A Lesson from Oprah
Oprah made a mistake. She came forth and took responsibility for it in her admission of error. Sh According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e apologized. She, and her adoring audience, moved on. There is a huge lesson for all of us here. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Everyone, from the most powerful leaders and opinion makers, companies large and small, to three-y lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ear old children, make mistakes. It is probably human nature that, when an error is discovered, ma here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe y of us immediately attempt to cover it up. We deny it, blame someone else or something outside ou d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro r control (the dog ate my homework), we launch a smokescreen to avoid admitting our humanity and th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc fear of our inability to be perfect. The cover-up gets bigger and bigger, often becoming much lar easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ger than the original mistake. While many get away with the deception, some get caught and are des nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically royed by it. Oprah triumphed because of her honesty and her integrity. For days after her admissi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ on of error the news media ran lead stories about the incident and the manner in which she faced th ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s potentially career destroying event. This big flap will be over and done with in short order; pr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a bably by the time this column is published. Her audience will forgive and forget but her brand wil dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod l glow, not because she is immune to error, but because she admits her human fallibility and didn’t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin attempt to hide it. With most people she has risen in stature because of her integrity and respect tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen for her audience. Contrast the long term effect of this incident to that of political, religious, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel business, scientific, and athletic icons who made errors, denied them, attempted to cover them up, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and got discovered in the deception. Not a pretty comparison. This Oprah incident is a lesson for y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products all of us. We all should remember it whenever we err. We can use this lesson to review our stand . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on personal and business ethics, to consider how we will react when we make a mistake. Once we kno elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip how we want to react, instill the Oprah ethos to the staff so we all can learn a lesson from Oprah tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Contractor Estimating - What They Need To Know How To Win New Graphic Design Clients And Keep Old Ones Coming Back Five Steps to a Successful CRM Implementation
|